Royal Bank of Canada
DMK

Royal Bank of Canada’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Royal Bank of Canada’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1
Closed – – 7842
2023
Q1 		$0 Hold
1
– – ﹤0.01% 7664
2022
Q4 		$0 Buy
+1
New +$11 ﹤0.01% 7941
2022
Q2 		– Sell
-71
Closed -$3K – 7884
2022
Q1 		$3K Buy
+71
New +$3.05K ﹤0.01% 7423
2021
Q4 		– Sell
-286
Closed -$19K – 8004
2021
Q3 		$19K Buy
+286
New +$20.9K ﹤0.01% 6731
2021
Q1 		– Sell
-3
Closed – – 7780
2020
Q4 		$0 Buy
+3
New +$133 ﹤0.01% 7367
2020
Q3 		– Sell
-92
Closed -$5.45K – 7042
2020
Q2 		$4K Hold
92
– – ﹤0.01% 6127
2020
Q1 		$3K Buy
92
+21
+30% +$891 ﹤0.01% 6229
2019
Q4 		$4K Sell
71
-16
-18% -$776 ﹤0.01% 6439
2019
Q3 		$5K Buy
87
+16
+23% +$1.15K ﹤0.01% 6061
2019
Q2 		$7K Hold
71
– – ﹤0.01% 6191
2019
Q1 		$11K Hold
71
– – ﹤0.01% 5954
2018
Q4 		$11K Sell
71
-33
-32% -$6.33K ﹤0.01% 5858
2018
Q3 		$26K Buy
104
+71
+215% +$16.8K ﹤0.01% 5555
2018
Q2 		$7K Hold
33
– – ﹤0.01% 5952
2018
Q1 		$8K Buy
33
+32
+3,200% +$8.4K ﹤0.01% 5805
2017
Q4 		$0 Buy
+1
New +$329 ﹤0.01% 7001
2017
Q3 		– Hold
0
– – – 7068
2015
Q4 		– Sell
-2
Closed – – 6878
2015
Q3 		$0 Hold
2
– – ﹤0.01% 6830
2015
Q2 		$0 Buy
+2
New +$604 ﹤0.01% 6764
2015
Q1 		– Hold
0
– – – 6472
2014
Q4 		– Hold
0
– – – 6337
2014
Q3 		– Hold
0
– – – 6174
2014
Q2 		– Hold
0
– – – 6193
2014
Q1 		– Hold
0
– – – 6204
2013
Q4 		– Hold
0
– – – 6203

Other funds holding DMK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Royal Bank of Canada's DMK Position: Q2 2023 in Review

Royal Bank of Canada sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q2 2023, closing a stake of 1 share.

Royal Bank of Canada first reported a position in DMK in Q2 2015 and held it in 18 quarters. The position peaked at $26K in Q3 2018. 22 funds tracked by Wall St. Rank hold DMK as of Q2 2023.

  • Royal Bank of Canada reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q2 2023 after selling out during the quarter.
  • Royal Bank of Canada sold 1 DMK Pharmaceuticals Corporation Common Stock share in Q2 2023.
  • Royal Bank of Canada first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q2 2015 and held it in 18 quarters.
  • Royal Bank of Canada's DMK Pharmaceuticals Corporation Common Stock position peaked at $26K in Q3 2018.
  • 22 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q2 2023.

Based on Royal Bank of Canada's 13F filing for Q2 2023, filed 14 Aug 2023.